$1.235
-0.015 (-1.20%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Matinas BioPharma Holdings Inc (MTNB) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting MTNB is Strong sell.
Matinas BioPharma Holdings Inc (MTNB) 20-Day simple moving average is 1.71, while Matinas BioPharma Holdings Inc (MTNB) share price is $—, making it Sell.
Matinas BioPharma Holdings Inc (MTNB) 60-Day simple moving average is 2.43, while Matinas BioPharma Holdings Inc (MTNB) share price is $—, making it Sell.
Technical Analysis for MTNB
AI Technical MTNBAs of 2026-11-07, the technical board for Matinas BioPharma Holdings Inc (MTNB) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $1.24 sits below the 10-day, 20-day, 60-day and 200-day moving averages and above the 5-day.
Momentum readings: RSI stands at 32.157, MACD stands at -0.366 (Sell), Stochastic %K stands at 23.714, Stochastic %D stands at 18.714 and CCI stands at -94.6.
MTNB trades below the 60-day SMA (2.43) and below the 200-day SMA (6.74). Immediate resistance sits at Classic R1 1.92, then R2 2.41. Support sits at Classic S1 0.96, then S2 0.48.
Matinas BioPharma Holdings Inc (MTNB) Support & Resistance Level
Matinas BioPharma Holdings Inc (MTNB) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 32.157 |
| STOCHk_14_3_3 | 23.714 |
| STOCHd_14_3_3 | 18.714 |
| CCI_20 | -94.600 |
| AO_5_34 | -0.926 |
| MOM_10 | -0.425 |
| MACD_12_26_9 | -0.366 |
Matinas BioPharma Holdings Inc (MTNB) Relative Strength Index (RSI_14) is 32.157, creating a Neutral signal.
Matinas BioPharma Holdings Inc (MTNB) Stochastic %K is 23.714, creating a Neutral signal.
Matinas BioPharma Holdings Inc (MTNB) Stochastic %D is 18.714, creating a Buy signal.
Matinas BioPharma Holdings Inc (MTNB) CCI_20 is -94.600, creating a Neutral signal.
Matinas BioPharma Holdings Inc (MTNB) Awesome Oscillator (AO) is -0.926, creating a Sell signal.
Matinas BioPharma Holdings Inc (MTNB) Momentum (MOM) is -0.425, creating a Sell signal.
Matinas BioPharma Holdings Inc (MTNB) Moving Average Convergence Divergence (MACD) is -0.366, creating a Sell signal.
Matinas BioPharma Holdings Inc (MTNB) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.195 | Buy |
| MA_10 | 1.438 | Sell |
| MA_20 | 1.705 | Sell |
| MA_60 | 2.430 | Sell |
| MA_200 | 6.737 | Sell |
| MA_250 | 7.720 | Sell |
Matinas BioPharma Holdings Inc (MTNB) 5-Day simple moving average is 1.195, while Matinas BioPharma Holdings Inc (MTNB) share price is $, making it a Buy.
Matinas BioPharma Holdings Inc (MTNB) 10-Day simple moving average is 1.438, while Matinas BioPharma Holdings Inc (MTNB) share price is $, making it a Sell.
Matinas BioPharma Holdings Inc (MTNB) 20-Day simple moving average is 1.705, while Matinas BioPharma Holdings Inc (MTNB) share price is $, making it a Sell.
Matinas BioPharma Holdings Inc (MTNB) 60-Day simple moving average is 2.430, while Matinas BioPharma Holdings Inc (MTNB) share price is $, making it a Sell.
Matinas BioPharma Holdings Inc (MTNB) 200-Day simple moving average is 6.737, while Matinas BioPharma Holdings Inc (MTNB) share price is $, making it a Sell.
Matinas BioPharma Holdings Inc (MTNB) 250-Day simple moving average is 7.720, while Matinas BioPharma Holdings Inc (MTNB) share price is $, making it a Sell.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.